SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 7th, 2021 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 7th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is entered into and effective as of March 9, 2021, by and between Alzamend Neuro, Inc., a Delaware corporation (the “Company”) and Digital Power Lending LLC, a California limited liability company (including its designees, successors and assigns, the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 2nd, 2021 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 2nd, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is entered into and effective as of March 9, 2021, by and between Alzamend Neuro, Inc., a Delaware corporation (the “Company”) and Digital Power Lending LLC, a California limited liability company (including its designees, successors and assigns, the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2021 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is entered into and effective as of March 9, 2021, by and between Alzamend Neuro, Inc., a Delaware corporation (the “Company”) and Digital Power Lending LLC, a California limited liability company (including its designees, successors and assigns, the “Purchaser”).